Henry Schein, Inc.

Equities

HSIC

US8064071025

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-16 pm EST			5-day change	1st Jan Change
79.98 ^USD	+2.43%		+5.06%	+5.82%

Jan. 18	Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%	MT
Jan. 18	Tetratherix executes global distribution & supply agreement with Henry Schein	RE

Transcript : Henry Schein, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 02

Published on 11/18/2025 at 10:50 am EST - Modified on 11/18/2025 at 11:50 am EST

S&P Capital IQ

Presenter Speech
Michael Sarcone (Analysts)

Hi, everyone. My name is Mike Sarcone. I'm an analyst on the U.S. Medical Supplies and Devices team. This is the session for Henry Schein. And with us from

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Henry Schein, Inc.

Jan. 18	Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%	MT
Jan. 18	Tetratherix executes global distribution & supply agreement with Henry Schein	RE
Jan. 15	Henry Schein enters distribution agreement for CytoChip's CLIA-waived hematology analyzer	RE
Jan. 15	Henry Schein Agrees to Distribute CytoChip's CitoCBC system	MT
Jan. 15	Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer	CI
Jan. 13	Henry Schein, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:00 PM
Jan. 13	Henry Schein Seeks M&A Opportunities	CI
Jan. 12	Henry Schein, Inc. Appoints Frederick M. Lowery as Chief Executive Officer, Effective March 2, 2026	CI
Jan. 12	Henry Schein Names Frederick Lowery Chief Executive Officer	MT
Jan. 12	Outset Medical, Inc. Announces Board Changes	CI
Jan. 12	Henry Schein Names Frederick Lowery Chief Executive	DJ
Jan. 12	Henry Schein, Inc. Announces the Appointment of Frederick M. Lowery to the Board of Directors, Effective March 2, 2026	CI
Dec. 23	Henry Schein Says it Expects to Name Next CEO by Mid-January 2026	MT
Dec. 23	Henry Schein amends private shelf agreement with PGIM - SEC filing	RE
Dec. 09	Barclays Initiates Henry Schein With Overweight Rating, $86 Price Target	MT
Dec. 02	Henry Schein, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 09:00 AM
Dec. 01	Henry Schein Becomes Exclusive US Distributor of vVARDIS' Curodont Treatment in January	MT
Dec. 01	Henry Schein, Inc. Expands Partnership with Vvardis	CI
Nov. 25	Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly	CI
Nov. 18	Henry Schein, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 02:30 PM
Nov. 12	Henry Schein, Inc. Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11:20 AM
Nov. 05	VideaHealth and Henry Schein One Launch the Impact Panel, Bringing AI-Driven Patient Education to Dentrix and Dentrix Ascend	CI
Nov. 05	JPMorgan Adjusts Price Target on Henry Schein to $78 From $80, Maintains Overweight Rating	MT
Nov. 05	Morgan Stanley Adjusts Price Target on Henry Schein to $58 From $55, Maintains Underweight Rating	MT
Nov. 05	Baird Adjusts Price Target on Henry Schein to $78 From $72, Maintains Neutral Rating	MT